NephroDI Therapeutics

Biopharma, Biotechnology, Health Care, Pharmaceutical
Founded in 2017-01-01
Philadelphia, Pennsylvania, United States
http://nephrodi.com/
For Profit

About NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney. The company was founded in 2017 by Jeff M. Sands, Janet D. Klein, Ish Khanna, and Ram Pillarisetti and is headquartered in Philadelphia, Pennsylvania.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 1600018 USD
  • Last Funding: 1600018 USD (Venture - Series Unknown)
  • Funding Status:

Technology Stack

NephroDI Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Biopharma, Biotechnology, Health Care, Pharmaceutical

Headquarters: Philadelphia, Pennsylvania, United States